Vertex had already announced results of the first corrector and moved into a large, phase III clinical trial with the hope of moving the proteins into a place where Kalydeco could make them work better.
University College London's part in the project has been to design and build an optical corrector for the camera - an array of five massive lenses that sit at the primary focus of the camera.
